Actively Recruiting
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Led by Mayo Clinic · Updated on 2026-04-29
635
Participants Needed
1
Research Sites
491 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
CONDITIONS
Official Title
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia
- Patients willing to provide written informed consent
You will not qualify if you...
- Unwillingness or inability to give blood samples
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
M
Michael Stachowitz
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here